Literature DB >> 8957673

The development of cowpea mosaic virus as a potential source of novel vaccines.

C Porta1, V E Spall, T Lin, J E Johnson, G P Lomonossoff.   

Abstract

Epitopes from human rhinovirus 14 (HRV-14) and human immunodeficiency virus type (HIV-1) have been expressed on the surface of particles of the plant virus, cowpea mosaic virus (CPMV). The chimaeras retain their ability to grow in plants and large quantities of virions can be easily purified. Immunological studies have shown that purified particles have the antigenic properties of the insert, and, in the case of the HIV-1 chimaera, can elicit the production of neutralising antibodies in mice. The chimaera containing the epitope from HRV-14 has been crystallised and the crystals shown to diffract to atomic resolution.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957673     DOI: 10.1159/000150478

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  12 in total

1.  Identification of immunogenic hot spots within plum pox potyvirus capsid protein for efficient antigen presentation.

Authors:  M Rosario Fernández-Fernández; Jorge L Martínez-Torrecuadrada; Fernando Roncal; Elvira Domínguez; Juan Antonio García
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Norovirus P particle, a novel platform for vaccine development and antibody production.

Authors:  Ming Tan; Pengwei Huang; Ming Xia; Ping-An Fang; Weiming Zhong; Monica McNeal; Chao Wei; Wen Jiang; Xi Jiang
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

3.  Endosomal toll-like receptors play a key role in activation of primary human monocytes by cowpea mosaic virus.

Authors:  Marwah M Albakri; Frank A Veliz; Steven N Fiering; Nicole F Steinmetz; Scott F Sieg
Journal:  Immunology       Date:  2019-11-15       Impact factor: 7.397

4.  Novel strategy for inhibiting viral entry by use of a cellular receptor-plant virus chimera.

Authors:  Ing Wei Khor; Tianwei Lin; Johannes P M Langedijk; John E Johnson; Marianne Manchester
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo.

Authors:  Nicole F Steinmetz; Marianne Manchester
Journal:  Biomacromolecules       Date:  2009-04-13       Impact factor: 6.988

6.  Cowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines.

Authors:  Adeline Miermont; Hannah Barnhill; Erica Strable; Xiaowei Lu; Katherine A Wall; Qian Wang; M G Finn; Xuefei Huang
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

7.  Guiding plant virus particles to integrin-displaying cells.

Authors:  Marisa L Hovlid; Nicole F Steinmetz; Burkhardt Laufer; Jolene L Lau; Jane Kuzelka; Qian Wang; Timo Hyypiä; Glen R Nemerow; Horst Kessler; Marianne Manchester; M G Finn
Journal:  Nanoscale       Date:  2012-05-15       Impact factor: 7.790

Review 8.  Molecular farming of pharmaceutical proteins.

Authors:  R Fischer; N Emans
Journal:  Transgenic Res       Date:  2000       Impact factor: 3.145

Review 9.  Use of macromolecular assemblies as expression systems for peptides and synthetic vaccines.

Authors:  G P Lomonossoff; J E Johnson
Journal:  Curr Opin Struct Biol       Date:  1996-04       Impact factor: 6.809

Review 10.  Exploiting plant virus-derived components to achieve in planta expression and for templates for synthetic biology applications.

Authors:  Keith Saunders; George P Lomonossoff
Journal:  New Phytol       Date:  2013-03-04       Impact factor: 10.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.